| # | Drug | Count |
|---|---|---|
| 0 | GEFITINIB | 9 |
| 1 | BEVACIZUMAB | 1 |
| 2 | DENOSUMAB | 1 |
| 3 | ETHIODIZED OIL | 1 |
| 4 | FLUOROURACIL | 1 |
| 5 | FLUOROURACIL CREAM, 0.5% | 1 |
| 6 | INCLISIRAN | 1 |
| 7 | MEROPENEM | 1 |
| 8 | OXALIPLATIN | 1 |
| 9 | PEMETREXED DISODIUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GEFITINIB | 9 | 0.0010 |
| 1 | ETHIODIZED OIL | 1 | 0.0008 |
| 2 | INCLISIRAN | 1 | 0.0001 |
| 3 | MEROPENEM | 1 | 0.0000 |
| 4 | PEMETREXED DISODIUM | 1 | 0.0000 |
| 5 | OXALIPLATIN | 1 | 0.0000 |
| 6 | FLUOROURACIL CREAM, 0.5% | 1 | 0.0000 |
| 7 | FLUOROURACIL | 1 | 0.0000 |
| 8 | BEVACIZUMAB | 1 | 0.0000 |
| 9 | DENOSUMAB | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Radiographic Contrast Agent [EPC] | 1 | 0.0000 |
| 1 | Penem Antibacterial [EPC] | 1 | 0.0000 |
| 2 | Kinase Inhibitor [EPC] | 9 | 0.0000 |
| 3 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 5 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |